# Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer

> **NCT00868114** · PHASE2 · TERMINATED · sponsor: **Leo W. Jenkins Cancer Center** · enrollment: 24 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** KLH-pulsed autologous dendritic cell vaccine

## Key facts

- **NCT ID:** NCT00868114
- **Lead sponsor:** Leo W. Jenkins Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2013-07
- **Final completion:** 2015-12
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2018-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868114, "Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00868114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*